MSH3 and juvenile Huntington disease: This result is consistent with previous studies in humans, in which increased MSH3 expression driven by polymorphism in the 5′ end of the gene was associated with increased somatic instability at the trinucleotide repeat involved in Huntington's disease (Flower et al. 2019).